Plain-English translation of NCT06401330 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new approach to treating children with favorable histology Wilms tumor (a kidney cancer that affects children). Instead of giving all children the same treatment, doctors will personalize the plan based on the tumor's specific characteristics—including the child's age, tumor size, and genetic features. The goal is to help some children avoid unnecessary chemotherapy while giving others more effective treatment combinations.
Current treatments for Wilms tumor work well, but many children receive chemotherapy even when they might be cured with surgery alone. This trial aims to spare some children from the side effects of unnecessary chemotherapy while improving outcomes for children whose tumors are more aggressive.
You likely qualify if…
You likely don't qualify if…
Your child will be assigned to a treatment group based on tumor characteristics—some children will receive surgery only with observation, while others will receive chemotherapy combined with surgery. Treatment typically lasts several months and involves regular visits to the hospital for chemotherapy infusions (if assigned) and imaging scans (ultrasound, CT, or MRI) to monitor progress. Throughout the trial, your child's care team will track how well the treatment is working and watch for any side effects.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
United States